Contract award record
NHS Framework for the NHS London Region, Branded Medicines - Tranche A
Tender value £301,101,314
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer and contract winner
Award value£191,062,951
- AwardedCompleted
- StartCompleted
- EndCompleted
Work description
NHS Framework for the NHS London Region, Branded Medicines - Tranche A, Annual Tranche - Cytokine Modulators and other products, and Dolutegravir / Lamivudine
Offer reference number: CM/PHR/16/5516
CM/PHR/16/5516/01 - London Tranche A - 1 September 2020 to 31 August 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/16/5516/02 - London Annual Tranche - Cytokine Modulators and other products - 1 September 2020 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/16/5516/03 - NHS Framework agreement for the supply of Dolutegravir / Lamivudine - North of England - 1 September 2020 - 28 February 2021, South of England - 1 September 2020 - 31 August 2021, Midlands & East - 1 September 2020 - 28 February 2022, all with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Related awards
From this contract winner
- option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months.
£36,522,476 ·